Allspring Global Investments Holdings LLC Decreases Position in HealthEquity, Inc. $HQY

Allspring Global Investments Holdings LLC lessened its stake in HealthEquity, Inc. (NASDAQ:HQY) by 10.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 796,472 shares of the company’s stock after selling 88,358 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in HealthEquity were worth $81,949,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the company. Farther Finance Advisors LLC increased its position in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after buying an additional 172 shares during the last quarter. WPG Advisers LLC bought a new position in shares of HealthEquity during the 1st quarter worth $28,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of HealthEquity by 176.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after acquiring an additional 418 shares during the period. Sellwood Investment Partners LLC purchased a new stake in HealthEquity in the 2nd quarter worth about $58,000. Finally, Larson Financial Group LLC raised its stake in HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company’s stock valued at $61,000 after acquiring an additional 642 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

HealthEquity stock opened at $93.23 on Tuesday. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $8.03 billion, a PE ratio of 56.50, a price-to-earnings-growth ratio of 1.30 and a beta of 0.47. The firm’s 50 day simple moving average is $91.66 and its 200 day simple moving average is $93.95.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $325.80 million during the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. As a group, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HQY shares. Royal Bank Of Canada increased their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. KeyCorp cut their price objective on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Barrington Research reissued an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a report on Friday, August 29th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price target on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $121.31.

Insider Activity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the company’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president directly owned 79,456 shares in the company, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.